US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acumen Pharmaceuticals, Inc.

1.20

+0.130012.15%

Post-market: 1.200.00000.00%19:56 EDT

Volume:383.45K

Turnover:432.51K

Market Cap:72.69M

PE:-0.62

High:1.21

Open:1.09

Low:1.06

Close:1.07

Loading ...

Overview Company News Filings

Acumen Pharmaceuticals, Inc. FY Basic EPS USD -1.71

THOMSON REUTERS

Acumen Pharmaceuticals, Inc. FY Income From Operations USD -114.017 Million

THOMSON REUTERS

Acumen Pharmaceuticals, Inc. FY Operating Expenses USD 114.017 Million

THOMSON REUTERS

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2024 and Business Highlights

BRIEF-Acumen Pharmaceuticals Completes Enrollment Of Altitude-Ad, A Phase 2 Clinical Trial Of Sabirnetug (Acu193) In Early Alzheimer’S Disease

Acumen Pharmaceuticals Inc - Topline Results Expected in Late 2026

THOMSON REUTERS

Acumen Pharmaceuticals Completes Enrollment of Altitude-Ad, a Phase 2 Clinical Trial of Sabirnetug (Acu193) in Early Alzheimer’s Disease

THOMSON REUTERS

Acumen Pharmaceuticals Inc expected to post a loss of 48 cents a share - Earnings Preview

Acumen Pharmaceuticals Inc expected to post a loss of 48 cents a share - Earnings Preview

BRIEF-Acumen Pharmaceuticals To Report Fourth Quarter And Year-End 2024 Financial Results On March 27, 2025

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

THOMSON REUTERS

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Acumen Pharmaceuticals Announces Topline Results From Phase 1 Study of Subcutaneous Formulation of Sabirnetug in Healthy Volunteers

THOMSON REUTERS

Acumen Pharmaceuticals Inc - Weekly Sc Administration of Sabirnetug Well-Tolerated

THOMSON REUTERS

Acumen Pharmaceuticals Inc - Phase 2 Altitude-Ad Study of Iv Sabirnetug Ongoing

THOMSON REUTERS

Acumen Pharmaceuticals Announces Topline Results from Phase 1 Study of Subcutaneous Formulation of Sabirnetug in Healthy Volunteers

Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer’s

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

Promising US Penny Stocks To Consider In January 2025

Simply Wall St.

Acumen announces Phase 1 INTERCEPT-AD study publication

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ABOS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABOS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABOS\",,,,,undefined,":{"symbol":"ABOS","market":"US","secType":"STK","nameCN":"Acumen Pharmaceuticals, Inc.","latestPrice":1.2,"timestamp":1749240000000,"preClose":1.07,"halted":0,"volume":383450,"hourTrading":{"tag":"盘后","latestPrice":1.2,"preClose":1.2,"latestTime":"19:56 EDT","volume":2216,"amount":2656.71,"timestamp":1749254204180},"delay":0,"floatShares":32929494,"shares":60573425,"eps":-1.931363,"marketStatus":"Market Closed","change":0.13,"latestTime":"06-06 16:00:00 EDT","open":1.09,"high":1.21,"low":1.06,"amount":432508.55465500004,"amplitude":0.140187,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.931363,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1625112000000,"exchange":"NASDAQ","adjPreClose":1.07,"preHourTrading":{"tag":"盘前","latestPrice":1.07,"preClose":1.07,"latestTime":"08:05 EDT","volume":28,"amount":28.709998799999997,"timestamp":1749211507977},"postHourTrading":{"tag":"盘后","latestPrice":1.2,"preClose":1.2,"latestTime":"19:56 EDT","volume":2216,"amount":2656.71,"timestamp":1749254204180},"volumeRatio":1.911957701083401,"impliedVol":2.1855,"impliedVolPercentile":0.988},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABOS\",,,,,undefined,":{"symbol":"ABOS","floatShares":32929494,"roa":"-31.31%","roe":"-55.68%","lyrEps":-1.705106,"volumeRatio":1.911957701083401,"shares":60573425,"dividePrice":0,"high":1.21,"amplitude":0.140187,"preClose":1.07,"low":1.06,"week52Low":0.8551,"pbRate":"0.47","week52High":3.6,"institutionHeld":0,"latestPrice":1.2,"eps":-1.931363,"divideRate":0,"volume":383450,"delay":0,"ttmEps":-1.931363,"open":1.09,"prevYearClose":1.72,"prevWeekClose":1.02,"prevMonthClose":1.02,"prevQuarterClose":1.1,"fiveDayClose":1.02,"twentyDayClose":1,"sixtyDayClose":1.28},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABOS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522755633","title":"Acumen Pharmaceuticals, Inc. FY Basic EPS USD -1.71","url":"https://stock-news.laohu8.com/highlight/detail?id=2522755633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522755633?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLX40B324:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2522595375","title":"Acumen Pharmaceuticals, Inc. FY Income From Operations USD -114.017 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522595375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522595375?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLX40B324:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABOS","BK4539","BK4139"],"gpt_icon":0},{"id":"2522375523","title":"Acumen Pharmaceuticals, Inc. FY Operating Expenses USD 114.017 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522375523","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522375523?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLX40B324:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ABOS","BK4139"],"gpt_icon":0},{"id":"2522759233","title":"Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2024 and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2522759233","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522759233?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073200,"startTime":"0","endTime":"0","summary":"Enrollment complete for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug  for the treatment of early Alzheimer’s disease. Topline results from the Phase 1 study investigating a subcutaneous sabirnetug formulation support further development of this dosing option for patients. Cash, cash equivalents and marketable securities of $231.5 million as of Dec. 31, 2024, expected to support current clinical and operational activities into the first half of 2027. In January 2025, the Company announced that the Journal of Prevention of Alzheimer’s Disease  published the results of its Phase 1 INTERCEPT-AD study, demonstrating that sabirnetug  was generally well-tolerated with dose- and exposure-dependent target engagement and reduction in amyloid plaques.The publication titled “INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's disease” is available online here.The publication titled “Biofluid biomarker ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acumen-pharmaceuticals-reports-financial-results-110000269.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","ABOS","BK4139"],"gpt_icon":0},{"id":"2522742168","title":"BRIEF-Acumen Pharmaceuticals Completes Enrollment Of Altitude-Ad, A Phase 2 Clinical Trial Of Sabirnetug (Acu193) In Early Alzheimer’S Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2522742168","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522742168?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:07","pubTimestamp":1742990844,"startTime":"0","endTime":"0","summary":"BRIEF-Acumen Pharmaceuticals Completes Enrollment Of Altitude-Ad, A Phase 2 Clinical Trial Of Sabirnetug (Acu193) In Early Alzheimer’S DiseaseMarch 26 (Reuters) - Acumen Pharmaceuticals Inc ABOS.O:ACU","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA7DG50M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ABOS"],"gpt_icon":0},{"id":"2522874180","title":"Acumen Pharmaceuticals Inc - Topline Results Expected in Late 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2522874180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522874180?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:00","pubTimestamp":1742990401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA7DG50M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABOS","BK4539","BK4139"],"gpt_icon":0},{"id":"2522720871","title":"Acumen Pharmaceuticals Completes Enrollment of Altitude-Ad, a Phase 2 Clinical Trial of Sabirnetug (Acu193) in Early Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2522720871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522720871?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:00","pubTimestamp":1742990401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA7DG50M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ABOS","BK4139"],"gpt_icon":0},{"id":"2522611073","title":"Acumen Pharmaceuticals Inc  expected to post a loss of 48 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2522611073","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522611073?lang=en_us&edition=fundamental","pubTime":"2025-03-25 20:39","pubTimestamp":1742906360,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals Inc  expected to post a loss of48cents a share - Earnings Preview Acumen Pharmaceuticals Inc ABOS.OQ ABOS.O is expected to show no change in quarterly revenue when it reports  r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nL5N3Q80ZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS"],"gpt_icon":0},{"id":"2521281301","title":"Acumen Pharmaceuticals Inc  expected to post a loss of 48 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521281301","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521281301?lang=en_us&edition=fundamental","pubTime":"2025-03-21 21:09","pubTimestamp":1742562546,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals Inc  expected to post a loss of48cents a share - Earnings Preview Acumen Pharmaceuticals Inc ABOS.OQ ABOS.O is expected to show no change in quarterly revenue when it reports  r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL8N3Q416D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS"],"gpt_icon":0},{"id":"2521919494","title":"BRIEF-Acumen Pharmaceuticals To Report Fourth Quarter And Year-End 2024 Financial Results On March 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2521919494","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521919494?lang=en_us&edition=fundamental","pubTime":"2025-03-21 04:43","pubTimestamp":1742503389,"startTime":"0","endTime":"0","summary":"BRIEF-Acumen Pharmaceuticals To Report Fourth Quarter And Year-End 2024 Financial Results On March 27, 2025March 20 (Reuters) - Acumen Pharmaceuticals Inc ABOS.O:ACUMEN PHARMACEUTICALS TO REPORT FOURT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA137S5L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ABOS","BK4139"],"gpt_icon":0},{"id":"2521496333","title":"Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2521496333","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521496333?lang=en_us&edition=fundamental","pubTime":"2025-03-21 04:00","pubTimestamp":1742500801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA137S5L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","ABOS"],"gpt_icon":0},{"id":"2521549667","title":"Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2521549667","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521549667?lang=en_us&edition=fundamental","pubTime":"2025-03-21 04:00","pubTimestamp":1742500800,"startTime":"0","endTime":"0","summary":"NEWTON, Mass., March  20, 2025  (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/20/3046680/0/en/Acumen-Pharmaceuticals-to-Report-Fourth-Quarter-and-Year-End-2024-Financial-Results-on-March-27-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","ABOS"],"gpt_icon":0},{"id":"2520918876","title":"Acumen Pharmaceuticals Announces Topline Results From Phase 1 Study of Subcutaneous Formulation of Sabirnetug in Healthy Volunteers","url":"https://stock-news.laohu8.com/highlight/detail?id=2520918876","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520918876?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:00","pubTimestamp":1742385601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nTUA7PNSFK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABOS","BK4539","BK4139"],"gpt_icon":0},{"id":"2520712188","title":"Acumen Pharmaceuticals Inc - Weekly Sc Administration of Sabirnetug Well-Tolerated","url":"https://stock-news.laohu8.com/highlight/detail?id=2520712188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520712188?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:00","pubTimestamp":1742385601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nTUA7PNSFK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ABOS","BK4539"],"gpt_icon":0},{"id":"2520188732","title":"Acumen Pharmaceuticals Inc - Phase 2 Altitude-Ad Study of Iv Sabirnetug Ongoing","url":"https://stock-news.laohu8.com/highlight/detail?id=2520188732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520188732?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:00","pubTimestamp":1742385601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nTUA7PNSFK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ABOS","BK4139"],"gpt_icon":0},{"id":"2520185769","title":"Acumen Pharmaceuticals Announces Topline Results from Phase 1 Study of Subcutaneous Formulation of Sabirnetug in Healthy Volunteers","url":"https://stock-news.laohu8.com/highlight/detail?id=2520185769","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520185769?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:00","pubTimestamp":1742385600,"startTime":"0","endTime":"0","summary":"Weekly subcutaneous administration of sabirnetug was well-tolerated in the Phase 1 study. Systemic exposure following subcutaneous administration supports further clinical development. Development of sabirnetug delivered subcutaneously has the potential for decreased treatment burden and increased patient convenience. Sabirnetug is the first humanized monoclonal antibody to clinically demonstrate selective target engagement of AβOs in patients with AD. The SC formulation of sabirnetug is co-formulated with Halozyme’s proprietary ENHANZE drug delivery technology  that enables large volume SC injection with increased dispersion and absorption of co-administered therapies. ENHANZE has been commercially validated as a component of nine approved therapies.Sabirnetug  is a humanized monoclonal antibody  discovered and developed based on its selectivity for soluble amyloid beta oligomers , which are a highly toxic and pathogenic form of Aβ, relative to Aβ monomers and amyloid plaques. Soluble","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acumen-pharmaceuticals-announces-topline-results-120000503.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4181","ABOS","BK4218","BK4539","BK4139","PK"],"gpt_icon":0},{"id":"2520679021","title":"Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2520679021","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520679021?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:48","pubTimestamp":1742302080,"startTime":"0","endTime":"0","summary":"NEW YORK, March 18, 2025  -- Today's Marketplace  is proud to announce a featured interview with Acumen Pharmaceuticals  CEO Daniel O’Connell and Jessica Clark, DNP, RN, Dean of the College of Nursing at Creighton University. The pair joined Today’s Marketplace host Elizabeth Hart to discuss Alzheimer’s Disease.The full interview can be viewed online here.“In the U.S., we have over six million people diagnosed with active Alzheimer’s today, and worldwide, about 55 million,” said Clark.Dr. Clark went on to say that the economic impact of this devastating disease could seem “insurmountable at times,” explaining that the treatment and long-term care costs associated with Alzheimer's are about $360 billion dollars. And that does not even consider the time investment and productivity losses experienced by caregivers.Acumen Pharmaceuticals is a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers  for the treatment of Alzhe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acumen-pharmaceuticals-ceo-discusses-novel-124800149.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4539","ABOS","TMP","NYSE","BK4211"],"gpt_icon":0},{"id":"2518620036","title":"Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2518620036","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518620036?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:00","pubTimestamp":1741636800,"startTime":"0","endTime":"0","summary":"NEWTON, Mass., March  10, 2025  (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble am","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/10/3040126/0/en/Acumen-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2506818855","title":"Promising US Penny Stocks To Consider In January 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2506818855","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506818855?lang=en_us&edition=fundamental","pubTime":"2025-01-25 04:10","pubTimestamp":1737749404,"startTime":"0","endTime":"0","summary":"As the U.S. equities market takes a breather from its recent rally, major indexes have slipped slightly after reaching record high levels. In this context, penny stocks—often associated with smaller or newer companies—continue to offer intriguing growth opportunities at lower price points. Despite being considered a somewhat outdated term, these stocks can still provide significant potential when backed by strong financials and fundamentals.Overview: Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for Alzheimer's disease, with a market cap of approximately $105.14 million.Jump into the full analysis health report here for a deeper understanding of Acumen Pharmaceuticals.Gain insights into Acumen Pharmaceuticals' future direction by reviewing our growth report.Overview: Sight Sciences, Inc. is an ophthalmic medical device company focused on developing and commercializing surgical and nonsurgical technologies for treatin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/promising-us-penny-stocks-consider-201004884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4082","BABB","BK4139","BK4209","SGHT","ABOS","VGZ"],"gpt_icon":0},{"id":"2502014955","title":"Acumen announces Phase 1 INTERCEPT-AD study publication","url":"https://stock-news.laohu8.com/highlight/detail?id=2502014955","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502014955?lang=en_us&edition=fundamental","pubTime":"2025-01-09 21:05","pubTimestamp":1736427912,"startTime":"0","endTime":"0","summary":"Acumen (ABOS) Pharmaceuticals announced that the Journal of Prevention of Alzheimer’s Disease published the results of the Phase 1 INTERCEPT-AD cli...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acumen-announces-phase-1-intercept-ad-study-publication?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acumen-announces-phase-1-intercept-ad-study-publication?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","ABOS"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":42,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABOS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"ABOS","fiscalQuarterEnding":"2025/03","expectedEps":-0.56,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.48},{"market":"US","date":"2025-03-27","symbol":"ABOS","fiscalQuarterEnding":"2024/12","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.62},{"market":"US","date":"2024-11-12","symbol":"ABOS","fiscalQuarterEnding":"2024/09","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.5},{"market":"US","date":"2024-08-13","symbol":"ABOS","fiscalQuarterEnding":"2024/06","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2024-05-14","symbol":"ABOS","fiscalQuarterEnding":"2024/03","expectedEps":-0.23,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"pre","actualEps":-0.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABOS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABOS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1702353600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABOS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABOS","date":"2025-06-06","current":-0.557526,"percent":0.982218,"low":-24.285355,"twenty":-6.43497,"median":-3.671385,"eighty":-1.8063,"high":-0.510632,"avg":-4.581772,"sd":3.835397,"marketCap":64813564},"quantilePoints":[{"date":"2021-07-02","current":-24.285355,"twenty":-23.282602,"median":-17.962584,"eighty":-17.962584,"marketCap":783858402},{"date":"2021-07-09","current":-22.632801,"twenty":-23.49497,"median":-22.453176,"eighty":-17.962584,"marketCap":730518925},{"date":"2021-07-16","current":-21.387398,"twenty":-22.821186,"median":-22.058,"eighty":-19.615112,"marketCap":690321058},{"date":"2021-07-23","current":-20.453346,"twenty":-22.762131,"median":-21.9622,"eighty":-20.489271,"marketCap":660172658},{"date":"2021-07-30","current":-18.537342,"twenty":-22.651961,"median":-21.004198,"eighty":-18.192479,"marketCap":598329786},{"date":"2021-08-06","current":-17.974516,"twenty":-22.525026,"median":-20.513221,"eighty":-17.962584,"marketCap":580163442},{"date":"2021-08-13","current":-18.166116,"twenty":-22.280735,"median":-19.189981,"eighty":-17.931406,"marketCap":586347730},{"date":"2021-08-20","current":-7.634154,"twenty":-22.15859,"median":-18.285866,"eighty":-17.71346,"marketCap":699288543},{"date":"2021-08-27","current":-8.252662,"twenty":-22.03884,"median":-17.992479,"eighty":-8.058274,"marketCap":755943865},{"date":"2021-09-03","current":-6.887527,"twenty":-21.617319,"median":-17.962584,"eighty":-7.680984,"marketCap":630897476},{"date":"2021-09-10","current":-7.510453,"twenty":-21.349078,"median":-17.950566,"eighty":-7.666847,"marketCap":687957479},{"date":"2021-09-17","current":-7.170273,"twenty":-21.061678,"median":-17.84279,"eighty":-7.521056,"marketCap":656797052},{"date":"2021-09-24","current":-7.130512,"twenty":-20.654527,"median":-17.663165,"eighty":-7.137581,"marketCap":653154924},{"date":"2021-10-01","current":-6.746154,"twenty":-20.541962,"median":-12.845778,"eighty":-7.060709,"marketCap":617947688},{"date":"2021-10-08","current":-5.942094,"twenty":-20.489271,"median":-8.093617,"eighty":-6.829211,"marketCap":544295770},{"date":"2021-10-15","current":-5.986273,"twenty":-20.209056,"median":-7.868304,"eighty":-6.749688,"marketCap":548342578},{"date":"2021-10-22","current":-6.35296,"twenty":-19.320509,"median":-7.709259,"eighty":-6.596828,"marketCap":581931091},{"date":"2021-10-29","current":-6.207168,"twenty":-18.460702,"median":-7.618691,"eighty":-6.547348,"marketCap":568576622},{"date":"2021-11-05","current":-6.573855,"twenty":-18.321792,"median":-7.510453,"eighty":-6.499634,"marketCap":602165134},{"date":"2021-11-12","current":-5.721198,"twenty":-18.237966,"median":-7.159228,"eighty":-6.436016,"marketCap":524061726},{"date":"2021-11-19","current":-4.290171,"twenty":-18.103846,"median":-7.121676,"eighty":-6.359144,"marketCap":399037384},{"date":"2021-11-26","current":-3.598348,"twenty":-18.003256,"median":-7.081915,"eighty":-6.245163,"marketCap":334689571},{"date":"2021-12-03","current":-3.398198,"twenty":-17.97213,"median":-6.960422,"eighty":-6.12853,"marketCap":316073222},{"date":"2021-12-10","current":-3.063165,"twenty":-17.962584,"median":-6.808005,"eighty":-5.947395,"marketCap":284911073},{"date":"2021-12-17","current":-2.993547,"twenty":-17.962584,"median":-6.759408,"eighty":-5.733568,"marketCap":278435822},{"date":"2021-12-23","current":-3.076218,"twenty":-17.962584,"median":-6.746154,"eighty":-4.668715,"marketCap":286125183},{"date":"2021-12-31","current":-2.941334,"twenty":-17.950566,"median":-6.693139,"eighty":-3.915978,"marketCap":273579383},{"date":"2022-01-07","current":-2.501875,"twenty":-17.902666,"median":-6.569437,"eighty":-3.533082,"marketCap":232704357},{"date":"2022-01-14","current":-2.340884,"twenty":-17.84279,"median":-6.560601,"eighty":-3.298123,"marketCap":217730337},{"date":"2022-01-21","current":-2.253863,"twenty":-17.84279,"median":-6.529676,"eighty":-3.128431,"marketCap":209636273},{"date":"2022-01-28","current":-2.179894,"twenty":-17.76615,"median":-6.50096,"eighty":-3.056203,"marketCap":202756318},{"date":"2022-02-04","current":-2.166841,"twenty":-17.67993,"median":-6.441318,"eighty":-3.000509,"marketCap":201542208},{"date":"2022-02-11","current":-2.345235,"twenty":-17.567365,"median":-6.368422,"eighty":-2.938723,"marketCap":218135040},{"date":"2022-02-18","current":-2.571492,"twenty":-17.399714,"median":-6.357377,"eighty":-2.830816,"marketCap":239179608},{"date":"2022-02-25","current":-2.488821,"twenty":-11.942176,"median":-6.255765,"eighty":-2.557568,"marketCap":231490247},{"date":"2022-03-04","current":-2.184245,"twenty":-8.282704,"median":-6.180661,"eighty":-2.531462,"marketCap":203161021},{"date":"2022-03-11","current":-2.397448,"twenty":-8.157235,"median":-6.127646,"eighty":-2.498394,"marketCap":222991479},{"date":"2022-03-18","current":-2.789046,"twenty":-8.090966,"median":-5.966392,"eighty":-2.491432,"marketCap":259414770},{"date":"2022-03-25","current":-2.236458,"twenty":-7.98582,"median":-5.942094,"eighty":-2.48534,"marketCap":208017460},{"date":"2022-04-01","current":-1.613202,"twenty":-7.858585,"median":-5.752123,"eighty":-2.459234,"marketCap":162297812},{"date":"2022-04-08","current":-1.609179,"twenty":-7.787898,"median":-4.68612,"eighty":-2.395708,"marketCap":161893080},{"date":"2022-04-14","current":-1.59711,"twenty":-7.743719,"median":-4.477268,"eighty":-2.375693,"marketCap":160678881},{"date":"2022-04-22","current":-1.653432,"twenty":-7.680984,"median":-4.068266,"eighty":-2.340884,"marketCap":166345139},{"date":"2022-04-29","current":-1.55375,"twenty":-7.636805,"median":-3.598348,"eighty":-2.293893,"marketCap":156316536},{"date":"2022-05-06","current":-1.465194,"twenty":-7.621784,"median":-3.48522,"eighty":-2.261695,"marketCap":147407303},{"date":"2022-05-13","current":-1.340411,"twenty":-7.576721,"median":-3.311177,"eighty":-2.229496,"marketCap":134853384},{"date":"2022-05-20","current":-1.703502,"twenty":-7.526357,"median":-3.263314,"eighty":-2.181634,"marketCap":140944377},{"date":"2022-05-27","current":-1.742663,"twenty":-7.455671,"median":-3.076218,"eighty":-2.166841,"marketCap":144184478},{"date":"2022-06-03","current":-1.801405,"twenty":-7.332853,"median":-3.063165,"eighty":-1.916589,"marketCap":149044629},{"date":"2022-06-10","current":-1.879727,"twenty":-7.165855,"median":-3.024005,"eighty":-1.875701,"marketCap":155524830},{"date":"2022-06-17","current":-1.61539,"twenty":-7.14465,"median":-3.002249,"eighty":-1.786719,"marketCap":133654151},{"date":"2022-06-24","current":-1.835671,"twenty":-7.130512,"median":-2.971792,"eighty":-1.762051,"marketCap":151879717},{"date":"2022-07-01","current":-2.305602,"twenty":-7.121676,"median":-2.934807,"eighty":-1.786719,"marketCap":190760925},{"date":"2022-07-08","current":-2.932178,"twenty":-7.093402,"median":-2.93023,"eighty":-1.786719,"marketCap":242602535},{"date":"2022-07-15","current":-3.079032,"twenty":-7.082799,"median":-2.928281,"eighty":-1.798468,"marketCap":254752912},{"date":"2022-07-22","current":-3.074136,"twenty":-7.053641,"median":-2.93023,"eighty":-1.805321,"marketCap":254347900},{"date":"2022-07-29","current":-2.662946,"twenty":-7.035969,"median":-2.893472,"eighty":-1.8063,"marketCap":220326843},{"date":"2022-08-05","current":-2.555254,"twenty":-6.916685,"median":-2.888122,"eighty":-1.829797,"marketCap":211416566},{"date":"2022-08-12","current":-2.643366,"twenty":-6.866321,"median":-2.848961,"eighty":-1.866889,"marketCap":218706793},{"date":"2022-08-19","current":-6.140146,"twenty":-6.966193,"median":-2.888122,"eighty":-1.87872,"marketCap":193604932},{"date":"2022-08-26","current":-7.052176,"twenty":-7.035969,"median":-2.893472,"eighty":-1.891475,"marketCap":222362150},{"date":"2022-09-02","current":-7.411849,"twenty":-7.058124,"median":-2.93023,"eighty":-1.921825,"marketCap":233703025},{"date":"2022-09-09","current":-8.657862,"twenty":-7.09585,"median":-2.939203,"eighty":-1.943364,"marketCap":272991055},{"date":"2022-09-16","current":-7.052176,"twenty":-7.137581,"median":-2.966444,"eighty":-1.985462,"marketCap":222362150},{"date":"2022-09-23","current":-5.947463,"twenty":-7.12521,"median":-2.997898,"eighty":-2.053302,"marketCap":187529464},{"date":"2022-09-30","current":-12.884029,"twenty":-7.15702,"median":-3.015395,"eighty":-2.099834,"marketCap":406246333},{"date":"2022-10-07","current":-12.614274,"twenty":-7.388838,"median":-3.045761,"eighty":-2.133486,"marketCap":397740677},{"date":"2022-10-14","current":-10.160785,"twenty":-7.596303,"median":-3.064346,"eighty":-2.159688,"marketCap":320379710},{"date":"2022-10-21","current":-9.813957,"twenty":-7.732232,"median":-3.076218,"eighty":-2.166841,"marketCap":309443867},{"date":"2022-10-28","current":-9.197373,"twenty":-7.820986,"median":-3.141484,"eighty":-2.166841,"marketCap":290002367},{"date":"2022-11-04","current":-8.169734,"twenty":-8.037325,"median":-3.289421,"eighty":-2.169452,"marketCap":257599868},{"date":"2022-11-11","current":-8.734935,"twenty":-8.202905,"median":-3.398198,"eighty":-2.176413,"marketCap":275421243},{"date":"2022-11-18","current":-6.490146,"twenty":-8.124064,"median":-3.535258,"eighty":-2.182505,"marketCap":248825726},{"date":"2022-11-25","current":-6.607567,"twenty":-8.09185,"median":-3.757163,"eighty":-2.187726,"marketCap":253327507},{"date":"2022-12-02","current":-5.977767,"twenty":-8.054616,"median":-4.220554,"eighty":-2.201649,"marketCap":229181590},{"date":"2022-12-09","current":-6.532845,"twenty":-7.992466,"median":-4.572991,"eighty":-2.219924,"marketCap":250462738},{"date":"2022-12-16","current":-6.105861,"twenty":-7.961637,"median":-5.156037,"eighty":-2.229496,"marketCap":234092624},{"date":"2022-12-23","current":-5.561458,"twenty":-7.929869,"median":-5.598819,"eighty":-2.233847,"marketCap":213220729},{"date":"2022-12-30","current":-5.764275,"twenty":-7.898102,"median":-5.598819,"eighty":-2.239939,"marketCap":220996533},{"date":"2023-01-06","current":-5.593482,"twenty":-7.822905,"median":-5.620168,"eighty":-2.253863,"marketCap":214448488},{"date":"2023-01-13","current":-6.66094,"twenty":-7.819707,"median":-5.703399,"eighty":-2.258214,"marketCap":255373772},{"date":"2023-01-20","current":-6.105861,"twenty":-7.811989,"median":-5.732251,"eighty":-2.265176,"marketCap":234092624},{"date":"2023-01-27","current":-5.817648,"twenty":-7.77923,"median":-5.773662,"eighty":-2.270397,"marketCap":223042797},{"date":"2023-02-03","current":-6.137885,"twenty":-7.767658,"median":-5.817648,"eighty":-2.274748,"marketCap":235320383},{"date":"2023-02-10","current":-6.084512,"twenty":-7.720746,"median":-5.860346,"eighty":-2.28606,"marketCap":233274118},{"date":"2023-02-17","current":-5.881695,"twenty":-7.652709,"median":-5.881695,"eighty":-2.2983,"marketCap":225498314},{"date":"2023-02-24","current":-5.593482,"twenty":-7.635921,"median":-5.838997,"eighty":-2.301318,"marketCap":214448488},{"date":"2023-03-03","current":-5.582807,"twenty":-7.615599,"median":-5.817648,"eighty":-2.301725,"marketCap":214039235},{"date":"2023-03-10","current":-4.86761,"twenty":-7.596303,"median":-5.817648,"eighty":-2.304051,"marketCap":186619295},{"date":"2023-03-17","current":-4.131064,"twenty":-7.55885,"median":-5.764275,"eighty":-2.311108,"marketCap":158380849},{"date":"2023-03-24","current":-4.184437,"twenty":-7.521056,"median":-5.732251,"eighty":-2.321021,"marketCap":160427113},{"date":"2023-03-31","current":-3.886544,"twenty":-7.451291,"median":-5.696476,"eighty":-2.334604,"marketCap":166561751},{"date":"2023-04-06","current":-3.656798,"twenty":-7.396509,"median":-5.678878,"eighty":-2.340884,"marketCap":156715736},{"date":"2023-04-14","current":-3.714235,"twenty":-7.347733,"median":-5.63618,"eighty":-2.342624,"marketCap":159177240},{"date":"2023-04-21","current":-3.829108,"twenty":-7.288533,"median":-5.625505,"eighty":-2.346976,"marketCap":164100248},{"date":"2023-04-28","current":-3.656798,"twenty":-7.222732,"median":-5.593482,"eighty":-2.360029,"marketCap":156715736},{"date":"2023-05-05","current":-3.876972,"twenty":-7.161437,"median":-5.593482,"eighty":-2.375693,"marketCap":166151501},{"date":"2023-05-12","current":-5.219914,"twenty":-7.141115,"median":-5.582807,"eighty":-2.377433,"marketCap":235073605},{"date":"2023-05-19","current":-5.092377,"twenty":-7.126978,"median":-5.566795,"eighty":-2.383554,"marketCap":229330096},{"date":"2023-05-26","current":-4.418252,"twenty":-7.114429,"median":-5.429439,"eighty":-2.39053,"marketCap":198971550},{"date":"2023-06-02","current":-4.554899,"twenty":-7.102566,"median":-5.219914,"eighty":-2.393967,"marketCap":205125310},{"date":"2023-06-09","current":-4.436471,"twenty":-7.097021,"median":-5.145256,"eighty":-2.397448,"marketCap":199792051},{"date":"2023-06-16","current":-5.110596,"twenty":-7.089836,"median":-5.134474,"eighty":-2.40528,"marketCap":230150597},{"date":"2023-06-23","current":-5.147036,"twenty":-7.086333,"median":-5.156037,"eighty":-2.436608,"marketCap":231791600},{"date":"2023-06-30","current":-4.381813,"twenty":-7.082799,"median":-5.134474,"eighty":-2.437538,"marketCap":197330548},{"date":"2023-07-07","current":-4.600448,"twenty":-7.064072,"median":-5.110596,"eighty":-2.437771,"marketCap":207176563},{"date":"2023-07-14","current":-5.575196,"twenty":-7.052176,"median":-5.110596,"eighty":-2.441687,"marketCap":251073379},{"date":"2023-07-21","current":-9.382079,"twenty":-7.085449,"median":-5.147036,"eighty":-2.448851,"marketCap":422512554},{"date":"2023-07-28","current":-9.253733,"twenty":-7.118052,"median":-5.210804,"eighty":-2.455753,"marketCap":416732628},{"date":"2023-08-04","current":-9.11897,"twenty":-7.240218,"median":-5.320122,"eighty":-2.463585,"marketCap":410663706},{"date":"2023-08-11","current":-8.752,"twenty":-7.404179,"median":-5.397952,"eighty":-2.467066,"marketCap":406906755},{"date":"2023-08-18","current":-7.965898,"twenty":-7.60092,"median":-5.429439,"eighty":-2.46806,"marketCap":370358476},{"date":"2023-08-25","current":-7.61739,"twenty":-7.695122,"median":-5.513668,"eighty":-2.473653,"marketCap":354155293},{"date":"2023-09-01","current":-7.492922,"twenty":-7.770568,"median":-5.575196,"eighty":-2.481859,"marketCap":348368442},{"date":"2023-09-07","current":-7.380902,"twenty":-7.767705,"median":-5.588145,"eighty":-2.487081,"marketCap":343160276},{"date":"2023-09-15","current":-6.85814,"twenty":-7.766715,"median":-5.593482,"eighty":-2.488821,"marketCap":318855501},{"date":"2023-09-22","current":-5.887296,"twenty":-7.732232,"median":-5.602525,"eighty":-2.490499,"marketCap":273718061},{"date":"2023-09-29","current":-5.19028,"twenty":-7.666847,"median":-5.593482,"eighty":-2.49255,"marketCap":241311695},{"date":"2023-10-06","current":-5.576128,"twenty":-7.637688,"median":-5.593482,"eighty":-2.494913,"marketCap":259250933},{"date":"2023-10-12","current":-5.177833,"twenty":-7.635038,"median":-5.579467,"eighty":-2.500134,"marketCap":240733009},{"date":"2023-10-20","current":-4.343904,"twenty":-7.620743,"median":-5.572132,"eighty":-2.501875,"marketCap":201961106},{"date":"2023-10-27","current":-4.007842,"twenty":-7.614901,"median":-5.561458,"eighty":-2.506226,"marketCap":186336608},{"date":"2023-11-03","current":-2.439556,"twenty":-7.6046,"median":-5.465632,"eighty":-2.494913,"marketCap":113422283},{"date":"2023-11-10","current":-2.315089,"twenty":-7.60092,"median":-5.420329,"eighty":-2.494913,"marketCap":107635432},{"date":"2023-11-17","current":-2.659529,"twenty":-7.580741,"median":-5.37478,"eighty":-2.491928,"marketCap":129625466},{"date":"2023-11-24","current":-2.815917,"twenty":-7.53696,"median":-5.352087,"eighty":-2.493172,"marketCap":137247792},{"date":"2023-12-01","current":-2.851561,"twenty":-7.510453,"median":-5.277407,"eighty":-2.501875,"marketCap":138985106},{"date":"2023-12-08","current":-3.338703,"twenty":-7.499934,"median":-5.233843,"eighty":-2.501875,"marketCap":162728395},{"date":"2023-12-15","current":-3.564452,"twenty":-7.477986,"median":-5.219914,"eighty":-2.514928,"marketCap":173731383},{"date":"2023-12-22","current":-3.754556,"twenty":-7.434321,"median":-5.195987,"eighty":-2.526809,"marketCap":182997056},{"date":"2023-12-29","current":-4.550617,"twenty":-7.40566,"median":-5.177833,"eighty":-2.530479,"marketCap":221797065},{"date":"2024-01-05","current":-4.776365,"twenty":-7.387091,"median":-5.160712,"eighty":-2.535132,"marketCap":232800053},{"date":"2024-01-12","current":-4.598143,"twenty":-7.374979,"median":-5.147036,"eighty":-2.538641,"marketCap":224113484},{"date":"2024-01-19","current":-4.372394,"twenty":-7.334851,"median":-5.132811,"eighty":-2.542883,"marketCap":213110496},{"date":"2024-01-26","current":-3.861489,"twenty":-7.296337,"median":-5.106041,"eighty":-2.547996,"marketCap":188208998},{"date":"2024-02-02","current":-3.695148,"twenty":-7.269758,"median":-5.063995,"eighty":-2.553047,"marketCap":180101533},{"date":"2024-02-09","current":-3.588215,"twenty":-7.205245,"median":-4.989418,"eighty":-2.562386,"marketCap":174889592},{"date":"2024-02-16","current":-3.718911,"twenty":-7.15702,"median":-4.86761,"eighty":-2.569752,"marketCap":181259742},{"date":"2024-02-23","current":-3.968423,"twenty":-7.141115,"median":-4.782644,"eighty":-2.574787,"marketCap":193420939},{"date":"2024-03-01","current":-5.120929,"twenty":-7.126978,"median":-4.809209,"eighty":-2.579729,"marketCap":249594086},{"date":"2024-03-08","current":-5.192218,"twenty":-7.114429,"median":-4.86761,"eighty":-2.579915,"marketCap":253068714},{"date":"2024-03-15","current":-4.859536,"twenty":-7.101574,"median":-4.916346,"eighty":-2.583683,"marketCap":236853785},{"date":"2024-03-22","current":-5.144692,"twenty":-7.095444,"median":-4.930825,"eighty":-2.589158,"marketCap":250752296},{"date":"2024-03-28","current":-4.703502,"twenty":-7.089836,"median":-4.895181,"eighty":-2.591477,"marketCap":246327089},{"date":"2024-04-05","current":-4.405231,"twenty":-7.085449,"median":-4.848419,"eighty":-2.599721,"marketCap":230706347},{"date":"2024-04-12","current":-4.462591,"twenty":-7.075967,"median":-4.782644,"eighty":-2.603221,"marketCap":233710336},{"date":"2024-04-19","current":-3.625138,"twenty":-7.052176,"median":-4.776365,"eighty":-2.611522,"marketCap":189852098},{"date":"2024-04-26","current":-3.659554,"twenty":-7.051055,"median":-4.746204,"eighty":-2.620676,"marketCap":191654491},{"date":"2024-05-03","current":-3.99224,"twenty":-7.046226,"median":-4.732967,"eighty":-2.645525,"marketCap":209077627},{"date":"2024-05-10","current":-4.095488,"twenty":-7.042536,"median":-4.709765,"eighty":-2.655033,"marketCap":214484807},{"date":"2024-05-17","current":-4.006249,"twenty":-7.031951,"median":-4.692829,"eighty":-2.658717,"marketCap":224097571},{"date":"2024-05-24","current":-3.651809,"twenty":-7.023828,"median":-4.668715,"eighty":-2.660212,"marketCap":204271245},{"date":"2024-05-31","current":-3.200703,"twenty":-7.013201,"median":-4.655071,"eighty":-2.662946,"marketCap":179037738},{"date":"2024-06-07","current":-2.674413,"twenty":-6.98883,"median":-4.622094,"eighty":-2.673339,"marketCap":149598647},{"date":"2024-06-14","current":-2.835522,"twenty":-6.957296,"median":-4.609791,"eighty":-2.674198,"marketCap":158610613},{"date":"2024-06-21","current":-2.373676,"twenty":-6.949257,"median":-4.600351,"eighty":-2.669182,"marketCap":132776309},{"date":"2024-06-28","current":-2.534785,"twenty":-6.949154,"median":-4.599198,"eighty":-2.662946,"marketCap":141788276},{"date":"2024-07-05","current":-2.545526,"twenty":-6.899852,"median":-4.564008,"eighty":-2.652004,"marketCap":142389073},{"date":"2024-07-12","current":-2.814041,"twenty":-6.88559,"median":-4.51846,"eighty":-2.608794,"marketCap":157409018},{"date":"2024-07-15","current":-3.028853,"twenty":-6.885106,"median":-4.51846,"eighty":-2.610652,"marketCap":169424973},{"date":"2024-08-02","current":-3.469219,"twenty":-6.884691,"median":-4.51846,"eighty":-2.611522,"marketCap":194057682},{"date":"2024-08-09","current":-2.942928,"twenty":-6.879299,"median":-4.495685,"eighty":-2.620676,"marketCap":164618591},{"date":"2024-08-16","current":-2.385074,"twenty":-6.863694,"median":-4.477268,"eighty":-2.603221,"marketCap":154705428},{"date":"2024-08-23","current":-2.602741,"twenty":-6.860444,"median":-4.459078,"eighty":-2.601639,"marketCap":168824176},{"date":"2024-08-30","current":-2.602741,"twenty":-6.848113,"median":-4.436471,"eighty":-2.601639,"marketCap":168824176},{"date":"2024-09-06","current":-2.10257,"twenty":-6.808005,"median":-4.418252,"eighty":-2.589519,"marketCap":136381096},{"date":"2024-09-13","current":-2.269294,"twenty":-6.789035,"median":-4.418252,"eighty":-2.579729,"marketCap":147195456},{"date":"2024-09-20","current":-2.389705,"twenty":-6.77836,"median":-4.405231,"eighty":-2.565691,"marketCap":155005827},{"date":"2024-09-27","current":-2.250769,"twenty":-6.772661,"median":-4.391706,"eighty":-2.545526,"marketCap":145993860},{"date":"2024-10-04","current":-2.213719,"twenty":-6.763825,"median":-4.381813,"eighty":-2.537904,"marketCap":143590669},{"date":"2024-10-11","current":-2.084045,"twenty":-6.75499,"median":-4.351551,"eighty":-2.52363,"marketCap":135179500},{"date":"2024-10-18","current":-2.463804,"twenty":-6.75036,"median":-4.324868,"eighty":-2.493172,"marketCap":159812209},{"date":"2024-10-25","current":-2.537904,"twenty":-6.746336,"median":-4.303834,"eighty":-2.493172,"marketCap":164618591},{"date":"2024-10-31","current":-2.806514,"twenty":-6.74619,"median":-4.290341,"eighty":-2.499318,"marketCap":182041727},{"date":"2024-11-08","current":-2.936188,"twenty":-6.746154,"median":-4.256095,"eighty":-2.501671,"marketCap":190452896},{"date":"2024-11-15","current":-1.919975,"twenty":-6.744338,"median":-4.235757,"eighty":-2.492861,"marketCap":156808220},{"date":"2024-11-22","current":-1.699288,"twenty":-6.743884,"median":-4.184437,"eighty":-2.487273,"marketCap":138784287},{"date":"2024-11-29","current":-1.669864,"twenty":-6.738951,"median":-4.141738,"eighty":-2.476886,"marketCap":136381096},{"date":"2024-12-06","current":-1.55952,"twenty":-6.732888,"median":-4.12513,"eighty":-2.463368,"marketCap":127369129},{"date":"2024-12-13","current":-1.522739,"twenty":-6.729504,"median":-4.092174,"eighty":-2.444359,"marketCap":124365140},{"date":"2024-12-20","current":-1.324121,"twenty":-6.714601,"median":-4.072455,"eighty":-2.437306,"marketCap":108143600},{"date":"2024-12-27","current":-1.390327,"twenty":-6.700464,"median":-4.039868,"eighty":-2.401761,"marketCap":113550780},{"date":"2025-01-03","current":-1.360902,"twenty":-6.686699,"median":-4.021508,"eighty":-2.390383,"marketCap":111147589},{"date":"2025-01-10","current":-1.250559,"twenty":-6.66094,"median":-4.007046,"eighty":-2.380443,"marketCap":102135622},{"date":"2025-01-17","current":-1.184353,"twenty":-6.644542,"median":-4.002969,"eighty":-2.373676,"marketCap":96728442},{"date":"2025-01-24","current":-1.272627,"twenty":-6.614962,"median":-3.980769,"eighty":-2.352041,"marketCap":103938015},{"date":"2025-01-31","current":-1.147571,"twenty":-6.580597,"median":-3.965855,"eighty":-2.338607,"marketCap":93724453},{"date":"2025-02-07","current":-1.081365,"twenty":-6.566786,"median":-3.94466,"eighty":-2.323016,"marketCap":88317273},{"date":"2025-02-14","current":-1.074009,"twenty":-6.564899,"median":-3.918151,"eighty":-2.312943,"marketCap":87716475},{"date":"2025-02-21","current":-1.015159,"twenty":-6.562308,"median":-3.912497,"eighty":-2.301318,"marketCap":82910093},{"date":"2025-02-28","current":-0.926885,"twenty":-6.560601,"median":-3.900465,"eighty":-2.293717,"marketCap":75700520},{"date":"2025-03-07","current":-0.912172,"twenty":-6.556757,"median":-3.891331,"eighty":-2.270478,"marketCap":74498924},{"date":"2025-03-14","current":-0.89746,"twenty":-6.544785,"median":-3.876972,"eighty":-2.264162,"marketCap":73297329},{"date":"2025-03-21","current":-0.868035,"twenty":-6.535112,"median":-3.858033,"eighty":-2.256474,"marketCap":70894138},{"date":"2025-03-28","current":-0.728096,"twenty":-6.530944,"median":-3.854577,"eighty":-2.230367,"marketCap":74505312},{"date":"2025-04-04","current":-0.584844,"twenty":-6.525172,"median":-3.844144,"eighty":-2.213719,"marketCap":59846543},{"date":"2025-04-11","current":-0.603787,"twenty":-6.521372,"median":-3.829108,"eighty":-2.194295,"marketCap":61784893},{"date":"2025-04-17","current":-0.580109,"twenty":-6.515538,"median":-3.829108,"eighty":-2.181634,"marketCap":59361956},{"date":"2025-04-25","current":-0.651143,"twenty":-6.502285,"median":-3.796141,"eighty":-2.168921,"marketCap":66630767},{"date":"2025-05-02","current":-0.633384,"twenty":-6.492658,"median":-3.771671,"eighty":-2.161623,"marketCap":64813564},{"date":"2025-05-09","current":-0.591948,"twenty":-6.483739,"median":-3.736733,"eighty":-2.105653,"marketCap":60573425},{"date":"2025-05-16","current":-0.526263,"twenty":-6.462771,"median":-3.718911,"eighty":-2.026703,"marketCap":61179159},{"date":"2025-05-23","current":-0.536684,"twenty":-6.443969,"median":-3.695118,"eighty":-1.923456,"marketCap":62390627},{"date":"2025-05-30","current":-0.547105,"twenty":-6.440173,"median":-3.689743,"eighty":-1.875701,"marketCap":63602096},{"date":"2025-06-06","current":-0.557526,"twenty":-6.43497,"median":-3.671385,"eighty":-1.8063,"marketCap":64813564}],"updateTime":1749408758474}}}